Apex Biotechnology Corporation operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Apex Biotechnology with three other
companies in this sector in Taiwan:
OK Biotech Co Ltd
sales of 1.23 billion Taiwanese Dollars [US$41.64 million]
Cowealth Medical Holding Co Ltd
(3.04 billion Taiwanese Dollars [US$102.55 million]
of which 96%
was Depar. B(Sale Reagent&Other)), and
(1.82 billion Taiwanese Dollars [US$61.47 million]
of which 100%
was Manufacturing Medical Equipment & Medica).
During the year ended December of 2017, sales at
Apex Biotechnology were 1.80 billion Taiwanese Dollars (US$60.63 million).
a very small
increase of 1.8%
versus 2016, when the company's sales were 1.76 billion Taiwanese Dollars.
Despite this increase, sales are still
below the level achieved in 2015, when Apex Biotechnology
reported sales of 1.85 billion Taiwanese Dollars.